istock-583798468markrubens-1-
MarkRubens / iStockphoto.com
26 June 2018Asia-Pacific

Australia’s competition regulator seeks to appeal Pfizer judgment

The Australian Competition and Consumer Commission ( ACCC) said yesterday that it has sought to appeal against a decision by the Full Federal Court of Australia in a case involving Pfizer.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Asia-Pacific
31 May 2018   A court has rejected an appeal by the Australian Competition and Consumer Commission, in a decision which confirmed that deals made by Pfizer in relation to generic cholesterol-lowering medication do not constitute a misuse of its market power.

More on this story

Asia-Pacific
31 May 2018   A court has rejected an appeal by the Australian Competition and Consumer Commission, in a decision which confirmed that deals made by Pfizer in relation to generic cholesterol-lowering medication do not constitute a misuse of its market power.

More on this story

Asia-Pacific
31 May 2018   A court has rejected an appeal by the Australian Competition and Consumer Commission, in a decision which confirmed that deals made by Pfizer in relation to generic cholesterol-lowering medication do not constitute a misuse of its market power.